Saturday, July 12, 2014

Medisse, A Dutch biomaterial company, successfully treated the first patient with the FlexiSurge Adhesion Barrier to me in about 5 years....

EDE, The Netherlands--()--Medisse BV, a leading innovator and developer of synthetic resorbable soft tissue implants, today announced the successful treatment of the first patient in a clinical trial for its first innovation, FlexiSurge® Adhesion Barrier, which is designed to reduce adhesions formed after open colorectal surgery procedures. The study, currently underway in the Netherlands, marks a significant milestone in the development of the Company’s first product to revolutionize patient care.
“We are happy to have successfully treated the first patient in the FlexiSurge study”
The study, being conducted in three hospitals in the Netherlands, will the safety of 

No comments: